Fill Finish Biopharmaceuticals market Share, Growth Analysis by 2035
Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.
This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.
The financial opportunity within the biologics fill finish services market has been analysed across the following segments:
Type of Packaging Container
Ampoules
Cartridges
Syringes
Vials
Type of Biologic
Antibodies
Cell Therapies
Gene Therapies
Oligonucleotides
Proteins / Peptides
Vaccines
Others
Therapeutic Area
Oncological Disorders
Autoimmune Disorders
Infectious Diseases
Cardiovascular Disorders
Other Disorders
Scale of Operation
Preclinical / Clinical
Commercial
Company Size
Large
Mid-sized
Small
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
AbbVie Contract Manufacturing
Asymchem
BioReliance
Boehringer Ingelheim BioXcellence
Catalent Biologics
Charles River Laboratories
Fareva
Fresenius Kabi
Glaxo SmithKline
Hetero Drugs
Intas Pharmaceuticals
Lonza
Patheon
Pierre Fabre
Recipharm
Samsun Biologics
Syngene
Takara Bio
Wacker Biotech
WuXi AppTec
WuXi Biologics
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Biologics Fill / Finish Service Providers: Market Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North America
7. Biologics Fill / Finish Service Providers in Europe
8. Biologics Fill / Finish Service Providers in Asia-Pacific
9. Recent Partnerships
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish
14. Regional Capability Assessment
15. Biologics Fill Finish Market Sizing and Opportunity Analysis
16. Future Growth Opportunities
17. Case Study: Robotic Systems in Fill / Finish Operations
18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish
19. Concluding Remarks
20. Executive Insights
21. Appendix 1: Tabulated Data
22. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen
News article
women's digital health market
Learn from experts: do you know about these emerging industry trends?
Bioavailability Enhancement Technologies
TIL Therapies: A New Paradigm in Cancer Treatment
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#FillFinishManufacturing #FillFinishManufacturingMarket #BiologicsFillFinish #MarketResearch #MarketInsights
